Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Dianthus Therapeutics (DNTH) Return on Equity (2018 - 2025)

Dianthus Therapeutics (DNTH) has 6 years of Return on Equity data on record, last reported at 0.31% in Q3 2025.

  • For Q3 2025, Return on Equity fell 12.0% year-over-year to 0.31%; the TTM value through Sep 2025 reached 0.31%, down 12.0%, while the annual FY2024 figure was 0.32%, 37.0% up from the prior year.
  • Return on Equity reached 0.31% in Q3 2025 per DNTH's latest filing, up from 0.37% in the prior quarter.
  • Across five years, Return on Equity topped out at 3.19% in Q2 2022 and bottomed at 1.1% in Q1 2022.
  • Average Return on Equity over 4 years is 0.37%, with a median of 0.19% recorded in 2024.
  • The widest YoY moves for Return on Equity: up 218bps in 2023, down -326bps in 2023.
  • A 4-year view of Return on Equity shows it stood at 1.71% in 2022, then crashed by -115bps to 0.25% in 2023, then grew by 2bps to 0.24% in 2024, then dropped by -26bps to 0.31% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.31% in Q3 2025, 0.37% in Q2 2025, and 0.29% in Q1 2025.